Personal profile
External positions
University of Copenhagen
Fingerprint
Explore the research areas in which Lars Erik Bryld is active. The research areas are based on the researcher's research output in the portal. Combined, the research areas form a unique ‘fingerprint’, which reflects the researcher's professional profile.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Changes in Drug Survival of Adalimumab Over Time in Patients with Psoriasis - A Nationwide Cohort Study
Hjort, G., Schwarz, C. W., Bryld, L. E., Ajgeiy, K. K., Rasmussen, M. K., Bertelsen, T., Hjuler, K. F., Dam, T. N., Loft, N. & Skov, L., 25 Mar 2026, (Published, E-pub ahead of print) In: Clinical and Experimental Dermatology. 8 p.Research output: Contribution to journal › Article › Research › peer-review
-
Comparative 2-year drug survival of bimekizumab and brodalumab in second-line treatment of psoriasis
Schwarz, C. W., Loft, N., Bryld, L. E., Nissen, C. V., Svendsen, M. T., Bertelsen, T., Hjuler, K. F., Dam, T. N., Rasmussen, M. K. & Skov, L., 24 Apr 2026, (Published, E-pub ahead of print) In: Journal of the American Academy of Dermatology.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis
Schwarz, C. W., Loft, N., Bryld, L. E., Nissen, C. V., Ajgeiy, K. K., Bertelsen, T., Hjuler, K. F., Dam, T. N., Iversen, L., Rasmussen, M. K. & Skov, L., 1 Feb 2026, In: JAMA Dermatology. 162, 2, p. 166-175 10 p.Research output: Contribution to journal › Article › Research › peer-review
-
Real-world Drug Survival of Biosimilar SB5 vs GP2017 Following a Mandatory Non-medical Switch from Adalimumab Originator for Psoriasis: A Nationwide Cohort Study
Sieborg, J., Maul, J.-T., Wu, J. J., Loft, N. N., Skov, L., Bryld, L. E., Rasmussen, M. K., Dam, T. N., Bertelsen, T., Ajgeiy, K. K., Thomsen, S. F., Thyssen, J. P., Egeberg, A. & Thein, D., 3 Mar 2025, In: Acta Dermato-Venereologica. 105, 6 p., adv42572.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Drug survival of biologic therapies for palmoplantar pustulosis: a nationwide study
Bertelsen, T., Egeberg, A., Skov, L., Rasmussen, M., Bryld, L., Funding, A., Ajgeiy, K. & Aagaard, D. T., Feb 2024, In: Journal of the European Academy of Dermatology and Venereology : JEADV. 38, 2, p. 332-339 8 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
Press/Media
-
Behandling af pustulosis palmoplantaris er ofte utilstrækkelig
24/03/24
1 item of Media coverage
Press/Media
-
Nogle psoriasispatienter kan sikkert seponere biologisk behandling
13/03/23
1 item of Media coverage
Press/Media